V. Corpus

Characterization df a [3H]Glycine Recognition Site as a Modulatory Site of the N‐Methyl‐D‐Aspartate Receptor Complex

R. Compton, W. Hood, Joseph B. Monihan, 1989, Journal of neurochemistry.

Reversal of enhanced muscle glucose transport after exercise: roles of insulin and glucose.

J. Zierath, J. Holloszy, G. Cartee, 1990, The American journal of physiology.

Interaction of guanidinium compounds and K+ channel modulators with imidazoline binding sites in rabbit kidney.

V. Corpus, G. M. Olins, S. Bressie, 1994, European journal of pharmacology.

In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.

D. Reitz, V. Corpus, E. H. Blaine, 1992, The Journal of pharmacology and experimental therapeutics.

Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists.

E G McMahon, J. Collins, D. Reitz, 1993, Journal of medicinal chemistry.

Effects of ATP on calcium binding to synaptic plasma membrane

A. Sun, V. Corpus, Albert Y. Sun, 1983, Neurochemical Research.

Pharmacology of SC‐52458, an Orally Active, Nonpeptide Angiotensin AT1 Receptor Antagonist

R. Schmidt, D. Reitz, V. Corpus, 1993, Journal of cardiovascular pharmacology.

NAD+-induced inhibition of phosphate transport in canine renal brush-border membranes. Mediation through a process other than or in addition to NAD+ hydrolysis.

M. Hammerman, V. Corpus, J. Morrissey, 1983, Biochimica et biophysica acta.

Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists.

D. Reitz, V. Corpus, J. P. Koepke, 1993, Journal of medicinal chemistry.